DOCSLIB.ORG

Medical Intelligence

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Medical Intelligence 1818. 6 53 PART III. MEDICAL INTELLIGENCE. LIST of DISEASES treated at the Neiv Town Dispen- sary, for the Quarters ending June Is/ and September Is# 1818. end. end. Qt- Or- Qf. end. Qr. end. June 1st. 1st. t Sept. Juue 1st. Sept. 1st. - Fcbris continua 255 127 Pneumonia - 51 19 ? 21 6 - ephemera I'leurodyne - 51 37 ? 5 1 intermittens Phthisis et Haemoptysis 24 26" ? remit tens infan- Asthma et Dyspucca - 18 12 - tum 82 4G Ilydrothorax - - 4 4 dentitionis - 36 41 Pertussis - - 24 19 Hydrocephalus - 10 10 I'alpitatio - - 7 8 Cephala;a - 74 61 JVlastodynia 9 7 Apoplexia 1 Hepatitis - 8 5 Epilepsia 7 5 H&*matemesis 2 2 - - Mania - 2 Icterus - 4 4 . - - Convulsio f) 2 Dyspepsia - 132 83 Chorea 1 Hysteria - 21 15 Ophthalmia 72 04 Enteritis 4 4 Amaurosis - - 4 Peritonitis 1 Staphyloma - 2 Colica et Obstipatio - 16 23 - Otalgia - 13 13 Cholera - 3 E pis taxis 1 1 Diarrhoea - - S3 69 Polypus nasi - ? 1 Dysenteria - 7 5 - Odontalgia - 27 18 Vermes - - - 48 51 Aphthaeet ulcera faucium 3 7 Tabes mesenterica - 4 10 Cynanche tonsillaris - 41 61 --11 * Physconi.r. laryngea - 1 Ascites ---44 ? trachealis -3 2 Hernia 2 7 parotidea - 9 3 Haepiorrhois - - 14 15 Catarrhns - - 179 70 Dvsuria - 8 9 651- Quarterly Report of the New Town Dispensary. Now end. end. end. Qr. end- Qr. Qr. Qr 1?' June 1st. 1st. June 1st. Sept. Sept. * Dysuria urethrals 6 2 Varicella - 11 4 Nephralgia 2 4 Rubeola 3 - 6 Gonorrhoea 11 9 Scarlatina 12 Inflammatio testis 3 4> Miliaria 1 2 uteri eta- Urticaria Haemorrhagia 3 bortus - -? 2 2 Strophulus Leucorrhcea Lichen 3 5 Scirrhus uteri Prurigo 4 Prolapsus ani . Lepra 6 13 Amenorrhcea et chk Psoriasis 2 gO 1 rosis Pityriasis - 1 Dysmenorrhcea Roseola 3 - Hydrops Eczema * Kheumatismus - Purpura 3 1 4 Paralysis Ecthyma 5 Asthenia 13 Impetigo 39 llachitis Porrigo - 27 91 Scrofula ossium et arti- Scabies _ . 95 culorum 17 24 Herpes 1 glandularur Acne 1 Caries et necrosis Lupus 1 Syphilis Scorbutus * - Pseudo-syphilis Tumores 22 Phlegmon Ulcus - -46 Faruuculus Ustio - 11 Anthrax Vulnus - 25 Paronychia Luxatio - 2 Pernio Coutusio et subluxatio 89 ^2 Fractura - - 11 Erysipelas ^ Erythema - Venae varicose 2 Variola Table of Fevers tvJiich have occurred at the Dispensary* No. of Fevers. Whole Cases. Proportion* ^ 5,/ Quarter ending March 1st 1818, 451 2572 ==. 1 in Quarter ending June 1st 1818, 255 2371 = 1 in 9*^ Quarter ending September 1st 1818, 127 2095 = 1 in 16.2 From the foregoing table of the cases of fever which have occur- red in the practice of the Dispensary, it would appear, that an abate- ment of the prevalence of the epidemic in Edinburgh has taken pi*06 the during the spring and summer. We arc aware, however, that records of the Dispensary do not afford accurate data for judging the the extent to which this has taken place ; for the inhabitants of city, having become aware of the danger arising from the contagi01* of the disease, and of the advantages to be derived from the immedi* ate removal of the sick to the hospital, patients have been mucp more frequently than before conveyed there, without any iutermcdi- 1818. Quarterly Report dfthe New Town Dispensary. 655 ate application having been made for the assistance df the Dispensary. Though, from this circumstance, therefore, there is reason to believe that the epidemic has not diminished to the extent which appears from the table prefixed, yet we are convinced, not only from the Very remarkable diminution in the number of cases of fever which have occurred at the Dispensary, but also from having observed that the disease has not spread so frequently in families, and among the children of the poor, that it has suffered a very considerable abate- ment. This abatement may, in some instances, be owing to the diminu- tion of the predisposing causes of fever, in consequence of the fine- ness of the season, and of the improvement of the circumstances of the poor ; but the opening of the fever hospital, which has, during the summer, afforded accommodation to almost all who have re- quired admission, seems also to have materially contributed to produce it. The opening of this hospital in February had a marked and sud- den effect in diminishing the number of applications to the Dispen- sary. We have had daily opportunities of observing the good ef- fects of the removal of the sick, and of the purifying the infected houses, in checking the progress of fever, where it otherwise must inevitably have spread; and, on the other hand, have witnessed seve- ral examples, where, from the neglect of these means, in consequence of the prejudices or carelessness of the patients and their friends, the has in circumstances in disease spread, which, there is every reason to believe, it might have been checked. At Quarry Holes, a village in the suburbs, consisting of a few small cottages, the fever was intro- duced, in the month of April, by a man who obstinately refused to be removed, and from him it has since been communicated to his own and to the neighbouring families, no fewer than seventeen in- dividuals, within our knowledge, having been attacked by the dis- ease in this small place. ? In the midwifery department, the number of deliveries, from the 1st March to the 31st August, were 138. Natural labours, - - 123 Instrumental, 1 Complex, 4 Premature and abortions, - 10 138 on account of In the instrumental case, the forceps were applied the cessation of the labour pains. one of Of the complex labours, three were cases of twins, and prolapsus of the funis umbiliculis, in which the patient was delivered turning. Edinburgh, October 1st 1818. a tube of M. Laennec has discovered, that, by interposing paper or of wood between the ear of the observer and the chest the pat ent, much the diseases of the information may be acquired concerning 656 Small-Pox after Vaccination, Nov. chest. The pulsations of the heart are thus rendered more audible* and, in phthisical patients, the voice seems to proceed from the chesty ?when one end of the tube is applied over those places where there arc tubercles ; and, according as the sound is clear, or rattling, we ma/" judge whether the cavity is empty, or contains pus. Extract of a Letterfrom John Astbury, M. D. April 1 Mh. On Saturday last, I was informed by the overseer of the poor f?r the parish of Eccleshall, that more than twenty persons had had the small.pox after vaccination in that parish, mostly of a mild nature. Extracts from a Letterfrom a Physician? in London. A Fatal Case of Small.Pox, Eighteen Years after Vaccination. The circumstances are stated to be truly lamentable. The sul>je<^ was an apprentice or assistant to a most respectable apothecary, and the son of an opulent tradesman. lie had been vaccinated when au infant, by a surgeon, supposed to be particularly well acquainted on the with the cow-pock. The eruption, not numerous, appeared third day from the attack of fever. The eruption afforded no relief \ on the contrary, on the sixth day, or perhaps 011 the fifth day, very great difficulty of breathing, with little cough, but no expectoration? came on; much oppression and pain of the posterior part of the chest was felt; the face was swelled, and an erysipelatous affection spread over th<S it, also apparently over the eyes, which were quite red ; pulse was very strong, and frequent; the eruptions few in number* cxcept on the visage, but they were quite distinct, flat and depres- sed in the middle, without any ring or areola at their bases, contain- and ing scarcely any lymph. On the seventh day from the fever, the lifth or sixth of the eruption, the patient died. On examination of the body after death, the right lung was found adhering to the costal pleura, firmly but recently, and the whole lung was gorge" ?with blood, and apparently in a state of high inflammation. It w-a? said, that the victim had been exposed to the company of several and persons ill of the small-pox, about a fortnight before his illness, that lie had been, during that time, living freely, and using great to bodily exertion, during the late hot weather. It may be proper mention, that a very large scar remained on the arm from inocula- tion. Consumption prevalent during the uniform high Temperature of th& Summer 1818. and The more than three months, perhaps, of unprecedented high uniform temperature of the summer 1818, neither seemed to impe(lc the progress of pulmonary consumption, nor to prevent its occur- > rence. cases after the hot season commence Many decisively began * and ran their career to a fatal termination at the closc of AuguS to Others, which began in the preceding spring and winter, seemed ho be rather accelerated than arrested in their march, by the jmonths of June, July, and August. 6 1818. Dr Thomson on Varioloid Diseases* 657 Additional Observations on Varioloid Diseases. By John Thomson1", M. D. &c. &c. " Dear Sin,?Since sending you the Observations on the Varioloid Disease, &c." 1 have had occasion to see twelve additional cases of it in Edinburgh. In two of these the disease has occurred in persons who had previously passed through small-pox. It has attacked, for the second time, a boy who had been inoculated with cow-pox ; and it has proved fatal in two instances in which the patients had not passed through small-pox or cow-pock inoculation. Having been informed by my friend Mr William Wood that a varioloid disease, similar to that which had occurred in Edinburgh, was prevailing in the town of Lanark, and at Air Owen's cotton mills in that neighbourhood, I visited that place, and found that the disease had prevailed very extensively in the town, but was then be- ginning to decline.
Load more

Recommended publications
  • Café Au Lait Spots As a Marker of Neuropaediatric Diseases
    Mini Review Open Access J Neurol Neurosurg Volume 3 Issue 5 - May 2017 DOI: 10.19080/OAJNN.2017.03.555622 Copyright © All rights are reserved by Francisco Carratalá-Marco Café Au Lait Spots as a Marker of Neuropaediatric Diseases Francisco Carratalá-Marco1*, Rosa María Ruiz-Miralles2, Patricia Andreo-Lillo1, Julia Dolores Miralles-Botella3, Lorena Pastor-Ferrándiz1 and Mercedes Juste-Ruiz2 1Neuropaediatric Unit, University Hospital of San Juan de Alicante, Spain 2Paediatric Department, University Hospital of San Juan de Alicante, Spain 3Dermatology Department, University Hospital of San Juan de Alicante, Spain Submission: March 22, 2017; Published: May 10, 2017 *Corresponding author: Francisco Carratalá-Marco, Neuropaediatric Unit, University Hospital of San Juan de Alicante, Spain, Tel: ; Email: Abstract Introduction: want to know in which The measure,Café au lait the spots presence (CALS) of isolated are shown CALS in representsthe normal a population risk factor forwithout neurological pathological disease. significance, although they could also be criteria for some neurologic syndromes. Unspecific association with general neurologic illnesses has been less frequently described. We Patients and methods: We set up an observational transversal study of cases, patients admitted for neuropaediatric reasons (NPP; n=49) excluding all the patients suffering from neurologic illnesses associated to CALS, and controls, a hospital simultaneously admitted pediatric population for non-neurologic causes (CP; n=101) since October 2012 to January 2013. The data were collected from the clinical reports at admission, and then analyzed by SPSS 22.0 statistical package, and the Stat Calc module of EpiInfo 7.0, following the ethics current rules of the institution for observational studies.
    [Show full text]
  • Study Guide Medical Terminology by Thea Liza Batan About the Author
    Study Guide Medical Terminology By Thea Liza Batan About the Author Thea Liza Batan earned a Master of Science in Nursing Administration in 2007 from Xavier University in Cincinnati, Ohio. She has worked as a staff nurse, nurse instructor, and level department head. She currently works as a simulation coordinator and a free- lance writer specializing in nursing and healthcare. All terms mentioned in this text that are known to be trademarks or service marks have been appropriately capitalized. Use of a term in this text shouldn’t be regarded as affecting the validity of any trademark or service mark. Copyright © 2017 by Penn Foster, Inc. All rights reserved. No part of the material protected by this copyright may be reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system, without permission in writing from the copyright owner. Requests for permission to make copies of any part of the work should be mailed to Copyright Permissions, Penn Foster, 925 Oak Street, Scranton, Pennsylvania 18515. Printed in the United States of America CONTENTS INSTRUCTIONS 1 READING ASSIGNMENTS 3 LESSON 1: THE FUNDAMENTALS OF MEDICAL TERMINOLOGY 5 LESSON 2: DIAGNOSIS, INTERVENTION, AND HUMAN BODY TERMS 28 LESSON 3: MUSCULOSKELETAL, CIRCULATORY, AND RESPIRATORY SYSTEM TERMS 44 LESSON 4: DIGESTIVE, URINARY, AND REPRODUCTIVE SYSTEM TERMS 69 LESSON 5: INTEGUMENTARY, NERVOUS, AND ENDOCRINE S YSTEM TERMS 96 SELF-CHECK ANSWERS 134 © PENN FOSTER, INC. 2017 MEDICAL TERMINOLOGY PAGE III Contents INSTRUCTIONS INTRODUCTION Welcome to your course on medical terminology. You’re taking this course because you’re most likely interested in pursuing a health and science career, which entails ­proficiency­in­communicating­with­healthcare­professionals­such­as­physicians,­nurses,­ or dentists.
    [Show full text]
  • Eye Disease 1 Eye Disease
    Eye disease 1 Eye disease Eye disease Classification and external resources [1] MeSH D005128 This is a partial list of human eye diseases and disorders. The World Health Organisation publishes a classification of known diseases and injuries called the International Statistical Classification of Diseases and Related Health Problems or ICD-10. This list uses that classification. H00-H59 Diseases of the eye and adnexa H00-H06 Disorders of eyelid, lacrimal system and orbit • (H00.0) Hordeolum ("stye" or "sty") — a bacterial infection of sebaceous glands of eyelashes • (H00.1) Chalazion — a cyst in the eyelid (usually upper eyelid) • (H01.0) Blepharitis — inflammation of eyelids and eyelashes; characterized by white flaky skin near the eyelashes • (H02.0) Entropion and trichiasis • (H02.1) Ectropion • (H02.2) Lagophthalmos • (H02.3) Blepharochalasis • (H02.4) Ptosis • (H02.6) Xanthelasma of eyelid • (H03.0*) Parasitic infestation of eyelid in diseases classified elsewhere • Dermatitis of eyelid due to Demodex species ( B88.0+ ) • Parasitic infestation of eyelid in: • leishmaniasis ( B55.-+ ) • loiasis ( B74.3+ ) • onchocerciasis ( B73+ ) • phthiriasis ( B85.3+ ) • (H03.1*) Involvement of eyelid in other infectious diseases classified elsewhere • Involvement of eyelid in: • herpesviral (herpes simplex) infection ( B00.5+ ) • leprosy ( A30.-+ ) • molluscum contagiosum ( B08.1+ ) • tuberculosis ( A18.4+ ) • yaws ( A66.-+ ) • zoster ( B02.3+ ) • (H03.8*) Involvement of eyelid in other diseases classified elsewhere • Involvement of eyelid in impetigo
    [Show full text]
  • Part 3: European Commission Activities in the Field of Rare Diseases
    2014 REPORT ON THE STATE OF THE ART OF RARE DISEASE ACTIVITIES IN EUROPE PART III: EUROPEAN COMMISSION ACTIVITIES IN THE FIELD OF RARE DISEASES This work was financed by the EUCERD Joint Action: Working for Rare Diseases N° 2011 22 01 2014 Report on the State of the Art of Rare Disease Activities in Europe – Part III: European Commission activities in the field of rare diseases This document has been produced by the Scientific Secretariat of the European Union Committee of Experts on Rare Diseases (EUCERD) Joint Action through the EUCERD Joint Action: Working for Rare Diseases (N° 2011 22 01, Coordinator: Kate Bushby, University of Newcastle, United Kingdom), within the European Union’s Second Programme of Community Action in the Field of Health. The European Union Committee of Experts on Rare Diseases (EUCERD) was established in 2009 and its mandate ended in 2013. It is replaced from 2014 by the Commission Expert Group on Rare Diseases. The EUCERD Joint Action continues to support the activities of the new Expert Group until 2015. More information on the activities of the former European Union Committee of Experts on Rare Diseases and the EUCERD Joint Action can be found at www.eucerd.eu. Disclaimer: The findings and conclusions in this report are those of the contributors and validating authorities, who are responsible for the contents; the findings and conclusions do not necessarily represent the views of the European Commission or national health authorities in Europe. Therefore, no statement in this report should be construed as an official position of the European Commission or a national health authority.
    [Show full text]
  • LIST of OCCUPATIONAL DISEASES (Revised 2010)
    LIST OF OCCUPATIONAL DISEASES (revised 2010) Identification and recognition of occupational diseases: Criteria for incorporating diseases in the ILO list of occupational diseases Occupational Safety and Health Series, No. 74 List of occupational diseases (revised 2010) Identification and recognition of occupational diseases: Criteria for incorporating diseases in the ILO list of occupational diseases INTERNATIONAL LABOUR OFFICE • GENEVA Copyright © International Labour Organization 2010 First published 2010 Publications of the International Labour Office enjoy copyright under Protocol 2 of the Universal Copyright Convention. Nevertheless, short excerpts from them may be reproduced without authorization, on condition that the source is indicated. For rights of reproduction or translation, application should be made to ILO Publications (Rights and Permissions), International Labour Office, CH-1211 Geneva 22, Switzerland, or by email: pubdroit@ ilo.org. The International Labour Office welcomes such applications. Libraries, institutions and other users registered with reproduction rights organizations may make copies in accordance with the licences issued to them for this purpose. Visit www.ifrro.org to find the reproduction rights organization in your country. ILO List of occupational diseases (revised 2010). Identification and recognition of occupational diseases: Criteria for incorporating diseases in the ILO list of occupational diseases Geneva, International Labour Office, 2010 (Occupational Safety and Health Series, No. 74) occupational disease / definition. 13.04.3 ISBN 978-92-2-123795-2 ISSN 0078-3129 Also available in French: Liste des maladies professionnelles (révisée en 2010): Identification et reconnaissance des maladies professionnelles: critères pour incorporer des maladies dans la liste des maladies professionnelles de l’OIT (ISBN 978-92-2-223795-1, ISSN 0250-412x), Geneva, 2010, and in Spanish: Lista de enfermedades profesionales (revisada en 2010).
    [Show full text]
  • ICD-10 International Statistical Classification of Diseases and Related Health Problems
    ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision Volume 2 Instruction manual 2010 Edition WHO Library Cataloguing-in-Publication Data International statistical classification of diseases and related health problems. - 10th revision, edition 2010. 3 v. Contents: v. 1. Tabular list – v. 2. Instruction manual – v. 3. Alphabetical index. 1.Diseases - classification. 2.Classification. 3.Manuals. I.World Health Organization. II.ICD-10. ISBN 978 92 4 154834 2 (NLM classification: WB 15) © World Health Organization 2011 All rights reserved. Publications of the World Health Organization are available on the WHO web site (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press through the WHO web site (http://www.who.int/about/licensing/copyright_form). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned.
    [Show full text]
  • FAQ REGARDING DISEASE REPORTING in MONTANA | Rev
    Disease Reporting in Montana: Frequently Asked Questions Title 50 Section 1-202 of the Montana Code Annotated (MCA) outlines the general powers and duties of the Montana Department of Public Health & Human Services (DPHHS). The three primary duties that serve as the foundation for disease reporting in Montana state that DPHHS shall: • Study conditions affecting the citizens of the state by making use of birth, death, and sickness records; • Make investigations, disseminate information, and make recommendations for control of diseases and improvement of public health to persons, groups, or the public; and • Adopt and enforce rules regarding the reporting and control of communicable diseases. In order to meet these obligations, DPHHS works closely with local health jurisdictions to collect and analyze disease reports. Although anyone may report a case of communicable disease, such reports are submitted primarily by health care providers and laboratories. The Administrative Rules of Montana (ARM), Title 37, Chapter 114, Communicable Disease Control, outline the rules for communicable disease control, including disease reporting. Communicable disease surveillance is defined as the ongoing collection, analysis, interpretation, and dissemination of disease data. Accurate and timely disease reporting is the foundation of an effective surveillance program, which is key to applying effective public health interventions to mitigate the impact of disease. What diseases are reportable? A list of reportable diseases is maintained in ARM 37.114.203. The list continues to evolve and is consistent with the Council of State and Territorial Epidemiologists (CSTE) list of Nationally Notifiable Diseases maintained by the Centers for Disease Control and Prevention (CDC). In addition to the named conditions on the list, any occurrence of a case/cases of communicable disease in the 20th edition of the Control of Communicable Diseases Manual with a frequency in excess of normal expectancy or any unusual incident of unexplained illness or death in a human or animal should be reported.
    [Show full text]
  • Comparison of the Effects of 13-Cis Retinoic Acid and Melatonin on the Viabilities of SH-SY5Y Neuroblastoma Cell Line
    www.jkns.or.kr http://dx.doi.org/10.3340/jkns.2015.57.3.147 Print ISSN 2005-3711 On-line ISSN 1598-7876 J Korean Neurosurg Soc 57 (3) : 147-151, 2015 Copyright © 2015 The Korean Neurosurgical Society Laboratory Investigation Comparison of the Effects of 13-cis Retinoic Acid and Melatonin on the Viabilities of SH-SY5Y Neuroblastoma Cell Line Murat Tosun, M.D., Ph.D.,1 Yasemin Soysal, Ph.D.,2 Nuket Gocmen Mas, M.D., Ph.D.,3 Hamit Selim Karabekir, M.D.4 1Department of Histology Embryology, Afyon Kocatepe University Medical Faculty, Afyonkarahisar, Turkey 2Department of Molecular Medicine, Dokuz Eylul University Health Sciences Institute, Izmir, Turkey Departments of Anatomy,3 Neurosurgery,4 Dokuz Eylul University Medical Faculty, Izmir, Turkey Objective : Neuroblastoma is one of common childhood tumors. Although its mortality is very high, there is no effective treatment yet. The aim of this project is to evaluate cytotoxic effects of melatonin (MLT) an endogen hormone and 13-cis retinoic acid (13-cis-RA) also named as isotretinoin an analogue of vitamin A on neuroblastoma SH-SY5Y cell line. Methods : In this study, SH-SY5Y cell line was used. After cell culture, the cells were exposed to different doses of MLT and 13-cis-RA. 24 and 48 hours later. While the viabilities was estimated with MTT cell viability assay test, apoptotic indexes were calculated after staining with TUNEL based apoptosis kit. Results : It was observed that MLT has very effective cytotoxic potential than 13-cis-RA on neuroblastoma cell line. At the same time, when MLT and 13-cis-RA were combined, this effect was potentiated.
    [Show full text]
  • Malignant Peripheral Nerve Sheath Tumor in the Maxilla: Report of a Rare Case
    Case Report Malignant Peripheral Nerve Sheath Tumor in the Maxilla: Report of a Rare Case Jahanshah Salehinejad1, Atefeh Nasseh1, Amir Hossein Jafarian2, Nazanin Bashardoust3 1 Dental Research Center, Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, Mashhad University of Medical Sciences, Mashhad, Iran 2 Department of Pathology, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran 3 Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, Gilan University of Medical Sciences, Rasht, Iran Received 28 January 2012 and Accepted 15 April 2012 Abstract Introduction Malignant peripheral nerve sheath tumor (MPNST) The principal malignancy of peripheral nerve origin is a rare malignant tumor that develops either from a is preferably called a malignant peripheral nerve sheath preexisting neurofibroma or de novo. The cell of origin tumor (MPNST). These tumors account for 5% of all is believed to be the Schwann cell and possibly other soft tissue sarcomas, with about half of such cases nerve sheath cells. In this report, we describe a rare case occurring in patients with neurofibromatosis type I. The of MPNST that arise from the socket of second left lesion is most common on the proximal portions of the maxillary molar that has been already extracted in a extremities and the trunk: only 10% to 15% of cases young man. He was referred to a dentist’s office with a occur in the head and neck (1). The cell of origin is tumor-like mass of soft tissue on his left maxillary believed to be the Schwann cell and possibly other gingiva. Biopsy and histopathologic examination was nerve sheath cells (2).
    [Show full text]
  • Prioritizing Zoonotic Diseases for Multisectoral, One Health Collaboration in the United States Workshop Summary
    Prioritizing Zoonotic Diseases for Multisectoral, One Health Collaboration in the United States Workshop Summary CS29887A ONE HEALTH ZOONOTIC DISEASE PRIORITIZATION WORKSHOP REPORT, UNITED STATES Photo 1. A brown bear in the forest. ii ONE HEALTH ZOONOTIC DISEASE PRIORITIZATION WORKSHOP REPORT, UNITED STATES TABLE OF CONTENTS Participating Organizations ........................................................................................................................................................... iv Executive Summary ............................................................................................................................................................................. 1 Background ............................................................................................................................................................................................ 21 Workshop Methods ....................................................................................................................................................................... 30 Recommendations for Next Steps ........................................................................................................................................... 35 APPENDIX A: Overview of the One Health Zoonotic Disease Prioritization Process ................................ 39 APPENDIX B: One Health Zoonotic Disease Prioritization Workshop Participants for the United States ...............................................................................................................................................................................
    [Show full text]
  • National Policy for Rare Diseases, 2021
    NATIONAL POLICY FOR RARE DISEASES, 2021 Table of Contents 1. BACKGROUND 2. RARE DISEASES – ISSUES & CHALLENGES 3. THE INDIAN SCENARIO 4. EXPERIENCES FROM OTHER COUNTRIES 5. NEED TO BALANCE COMPETING PRIORITIES 6. DEFINITION & DISEASES COVERED 7. POLICY DIRECTION 8. PREVENTION AND CONTROL 9. CENTRES OF EXCELLENCE AND NIDAN KENDRA 10. GOVERNMENT OF INDIA SUPPORT IN TREATMENT 11. DEVELOPMENT OF MANPOWER 12. CONSTITUTION OF CONSORTIUM 13. INCREASING AFFORDABILITY OF DRUG RELATED TO RARE DISEASES 14. IMPLEMENTATION STRATEGY 2 1. Background Ministry of Health and family Welfare, Government of India formulated a National Policy for Treatment of Rare Diseases (NPTRD) in July, 2017. Implementation of the policy, however, faced certain challenges. A limiting factor in its implementation was bringing States on board and lack of clarity on how much Government could support in terms of tertiary care. Public Health and Hospitals is primarily a State subject. Stakeholder consultation with the State Governments at the draft stage of formulation of the policy could not be done in an elaborate manner. When the policy was shared with State Governments, issues such as cost effectiveness of interventions for rare disease vis- a-vis other health priorities, the sharing of expenditure between Central and State Governments, flexibility to State Governments to accept the policy or change it according to their situation, were raised by some of the State Governments. In the circumstances, though framed with best intent, the policy had implementation challenges and gaps, including the issue of cost effectiveness of supporting such health interventions for limited resource situation, which made it not feasible to implement.
    [Show full text]
  • History of the Statistical Classification of Diseases and Causes of Death
    Copyright information All material appearing in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated. Suggested citation Moriyama IM, Loy RM, Robb-Smith AHT. History of the statistical classification of diseases and causes of death. Rosenberg HM, Hoyert DL, eds. Hyattsville, MD: National Center for Health Statistics. 2011. Library of Congress Cataloging-in-Publication Data Moriyama, Iwao M. (Iwao Milton), 1909-2006, author. History of the statistical classification of diseases and causes of death / by Iwao M. Moriyama, Ph.D., Ruth M. Loy, MBE, A.H.T. Robb-Smith, M.D. ; edited and updated by Harry M. Rosenberg, Ph.D., Donna L. Hoyert, Ph.D. p. ; cm. -- (DHHS publication ; no. (PHS) 2011-1125) “March 2011.” Includes bibliographical references. ISBN-13: 978-0-8406-0644-0 ISBN-10: 0-8406-0644-3 1. International statistical classification of diseases and related health problems. 10th revision. 2. International statistical classification of diseases and related health problems. 11th revision. 3. Nosology--History. 4. Death- -Causes--Classification--History. I. Loy, Ruth M., author. II. Robb-Smith, A. H. T. (Alastair Hamish Tearloch), author. III. Rosenberg, Harry M. (Harry Michael), editor. IV. Hoyert, Donna L., editor. V. National Center for Health Statistics (U.S.) VI. Title. VII. Series: DHHS publication ; no. (PHS) 2011- 1125. [DNLM: 1. International classification of diseases. 2. Disease-- classification. 3. International Classification of Diseases--history. 4. Cause of Death. 5. History, 20th Century. WB 15] RB115.M72 2011 616.07’8012--dc22 2010044437 For sale by the U.S.
    [Show full text]